Search research articles
Contact Us
Filters
Showing results (81-90 of 127) with videos related to
Page
of 13
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 3, 2021
mTORC1 - a potential player in the pathogenesis of hidradenitis suppurativa?
A Dmitriev, A König, V Lang, et al.
Journal of Virology
|
July 1, 1994
A novel, glycan-dependent epitope in the V2 domain of human immunodeficiency virus type 1 gp120 is recognized by a highly potent, neutralizing chimpanzee monoclonal antibody
S V Warrier, A Pinter, W J Honnen, et al.
Journal of Virology
|
September 1, 1992
Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein
M Thali, C Furman, D D Ho, et al.
The Journal of Dermatological Treatment
|
February 4, 2020
Changing within the same class: efficacy of brodalumab in plaque psoriasis after treatment with an IL-17A blocker - a retrospective multicenter study
C Kromer, D Wilsmann-Theis, S Gerdes, et al.
Journal of Virology
|
November 24, 2006
Type-specific epitopes targeted by monoclonal antibodies with exceptionally potent neutralizing activities for selected strains of human immunodeficiency virus type 1 map to a common region of the V2 domain of gp120 and differ only at single positions from the clade B consensus sequence
W J Honnen, C Krachmarov, S C Kayman, et al.
Virology
|
October 30, 1979
Monoclonal antibodies against murine leukemia viruses: identification of six antigenic determinants on the p 15(E) and gp70 envelope proteins
M E Lostrom, M R Stone, M Tam, et al.
Journal of Virology
|
December 1, 1992
Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to a component of the CD4 binding site in the fourth conserved region
R Wyatt, M Thali, S Tilley, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 11, 2023
Randomized Phase 3 trial demonstrating high efficacy, favourable safety and convenience of a novel calcipotriol and betamethasone dipropionate cream for the treatment of psoriasis
A Pinter, A Reich, P Arenberger, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 17, 2020
A phase 4, randomized, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE)
A Pinter, M Hoffmann, K Reich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 31, 2023
A novel calcipotriol and betamethasone dipropionate (CAL/BDP) PAD-cream demonstrates greater improvements in daily activities and personal relationships than CAL/BDP gel/TS: A post-hoc analysis of DLQI outcomes from two phase 3 placebo-controlled randomized clinical trials in mild-to-moderate psoriasis
B Halioua, G Caillet, C Taieb, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 127) with videos related to
Sort By:
Page
of 13
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 3, 2021
mTORC1 - a potential player in the pathogenesis of hidradenitis suppurativa?
A Dmitriev, A König, V Lang, et al.
Journal of Virology
|
July 1, 1994
A novel, glycan-dependent epitope in the V2 domain of human immunodeficiency virus type 1 gp120 is recognized by a highly potent, neutralizing chimpanzee monoclonal antibody
S V Warrier, A Pinter, W J Honnen, et al.
Journal of Virology
|
September 1, 1992
Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein
M Thali, C Furman, D D Ho, et al.
The Journal of Dermatological Treatment
|
February 4, 2020
Changing within the same class: efficacy of brodalumab in plaque psoriasis after treatment with an IL-17A blocker - a retrospective multicenter study
C Kromer, D Wilsmann-Theis, S Gerdes, et al.
Journal of Virology
|
November 24, 2006
Type-specific epitopes targeted by monoclonal antibodies with exceptionally potent neutralizing activities for selected strains of human immunodeficiency virus type 1 map to a common region of the V2 domain of gp120 and differ only at single positions from the clade B consensus sequence
W J Honnen, C Krachmarov, S C Kayman, et al.
Virology
|
October 30, 1979
Monoclonal antibodies against murine leukemia viruses: identification of six antigenic determinants on the p 15(E) and gp70 envelope proteins
M E Lostrom, M R Stone, M Tam, et al.
Journal of Virology
|
December 1, 1992
Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to a component of the CD4 binding site in the fourth conserved region
R Wyatt, M Thali, S Tilley, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 11, 2023
Randomized Phase 3 trial demonstrating high efficacy, favourable safety and convenience of a novel calcipotriol and betamethasone dipropionate cream for the treatment of psoriasis
A Pinter, A Reich, P Arenberger, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 17, 2020
A phase 4, randomized, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE)
A Pinter, M Hoffmann, K Reich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 31, 2023
A novel calcipotriol and betamethasone dipropionate (CAL/BDP) PAD-cream demonstrates greater improvements in daily activities and personal relationships than CAL/BDP gel/TS: A post-hoc analysis of DLQI outcomes from two phase 3 placebo-controlled randomized clinical trials in mild-to-moderate psoriasis
B Halioua, G Caillet, C Taieb, et al.
Page
of 13